(Press-News.org) What does it take for a company to last for centuries? Ask most business analysts, and you’ll hear about innovation, financial acumen, or strategic pivots. But new research suggests another key to organizational survival: environmental sustainability. In a study recently published in Frontiers in Organizational Psychology, an international team of researchers reveals a robust link between organizations’ longevity and their commitment to environmentally sustainable business practices. The findings challenge the assumption that younger, more agile companies are best positioned to lead on climate and environmental issues.
The study explores whether firms that have stood the test of time — some over a century old — are also those most committed to preserving the planet. It’s a timely question. As climate change accelerates and the call for corporate accountability grows louder, understanding the organizational characteristics associated with environmental responsibility is more critical than ever.
The study analyzed data from hundreds of firms including industry leaders in tech, manufacturing, and finance in the United States, Europe, the Middle East and North Africa (MENA), and Asia. Our goal was simple yet ambitious: determine whether older organizations exhibit stronger environmental sustainability performance than younger ones. To answer this, our team analyzed environmental, social, and governance (ESG) ratings drawn from multiple independent sources, including CSRHub, S&P Global, and Thomson Reuters, that evaluate companies on dimensions of climate strategy, eco-efficiency, and environmental reporting.
Standing the test of time
The results were striking. In every region examined, older organizations outperformed their younger counterparts on environmental metrics. These effects held even when accounting for company size and wealth, suggesting that longevity itself — not just financial clout — correlates with environmental stewardship. In the United States, for example, companies established more than a century ago showed markedly higher sustainability scores than those formed in the last two decades. The same pattern emerged in MENA and Asian markets. The effect was slightly less pronounced in Europe, likely due to limited availability of incorporation dates of companies in that region, rather than reflecting a substantive difference in sustainability performance.
Beyond establishing this link, our paper takes a deeper dive into why older organizations might be greener, building on evolutionary theories of organizations, resource dependence theory, and psychological frameworks like Cybernetic Trait Complexes Theory. Our central thesis: surviving over time requires adaptation—not just to markets, but to environmental and societal demands. Organizations that endure are those that have learned to navigate resource scarcity, respond to public scrutiny, and build sustainable systems into their operations. In this light, sustainability is not an add-on; it is a survival strategy.
The implications of this work extend beyond theory. One key takeaway is that sustainability is not just the domain of startups or mission-driven newcomers. Older firms, often seen as sluggish or resistant to change, may in fact be the most effective stewards of sustainability, thanks to decades of institutional knowledge, established systems, and embedded norms. These organizations are not only capable of setting long-term goals; they often have the operational discipline and stakeholder networks to see those goals through.
Green shoots of growth
Our findings also carry weight for policy and practice. Policymakers might consider designing incentives that recognize the sustainability strengths of mature organizations, while also supporting younger companies in building long-term environmental strategies. For investors, the message is equally compelling. ESG scores are increasingly used to evaluate corporate risk and resilience. If sustainability performance is a signal of adaptability and thus of long-term viability, then green credentials may offer a glimpse into a company’s staying power.
Still, we must be careful not to paint a one-sided picture. Of course, some legacy firms emerged from eras of industrial pollution and ecological harm. Nonetheless, what matters is not where these companies started but how they have evolved. Our data show that many older firms have adapted meaningfully, outperforming younger peers even in innovation-related sustainability metrics.
Perhaps most powerfully, we believe these data call for a new narrative about sustainability in business. Sustainability is not a generational rivalry. It is not a race between new and old, small and large, or East and West; it is a test of adaptation, a shared evolutionary journey where the most enduring organizations are often those that embrace sustainability as central to who they are. The climate crisis is rewriting what it means to lead in business, and in this new chapter, the champions will be not only the boldest or the strongest, but the greenest.
END
Survival of the greenest: Why world’s oldest organizations are surpassing young upstarts in environmental sustainability
2025-06-05
ELSE PRESS RELEASES FROM THIS DATE:
Have female earwigs evolved their forceps as weapons in battles for mates?
2025-06-05
A new study from Toho University reveals that female earwigs exhibit a similar pattern of exaggerated forceps growth as males, suggesting that both sexes may have evolved these traits through sexual selection.
Do larger male elk have proportionally larger antlers? The answer is no. In fact, larger individuals tend to have disproportionately larger antlers—a phenomenon known as positive allometry. This pattern, where certain body parts grow disproportionately large relative to body size, is observed not only in mammals ...
Baby's microbiome may protect against childhood viral infection
2025-06-04
A baby's makeup of gut bacteria — their microbiome — which starts to form as soon as they are born, could help protect against viral infections later in childhood, a new study suggests.
As part of the largest study of UK baby microbiomes to date, researchers at the Wellcome Sanger Institute and University College London (UCL) found that babies with a specific mix of gut bacteria at one week old, which was only found in some babies born vaginally, were less likely to be hospitalised for viral lower respiratory tract infections (vLRTI) in the first two years of life.
This research, published today ...
Diabetes drug shows benefits for patients with liver disease
2025-06-04
The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical trial from China published by The BMJ today.
The results show that treatment with dapagliflozin improved metabolic dysfunction-associated steatohepatitis (MASH) - a condition where excess fat accumulates in the liver, leading to inflammation - and liver fibrosis (a build up of scar tissue) compared ...
P2Y12 drugs may be better than aspirin to prevent heart attack and stroke in patients with coronary artery disease
2025-06-04
Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death, heart attack and stroke compared with traditional aspirin, with no increased risk of major bleeding, finds a study published by The BMJ today.
P2Y12 inhibitors are often given to patients alongside aspirin (“dual therapy”) after percutaneous coronary intervention (PCI) - a procedure to widen or unblock a coronary artery - to help prevent cardiovascular events including heart attack and stroke.
After several months, patients ...
Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
2025-06-04
(Vienna, Austria, Thursday 5 June 2025) New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as a disease-modifying treatment for IgA nephropathy (IgAN). Findings presented today at the 62nd ERA Congress demonstrate sustained proteinuria remission, stable kidney function, and a reassuring safety profile.1
IgAN is the most common form of glomerular disease worldwide and a frequent cause of chronic kidney disease. Its pathogenesis is marked by inflammation and progressive kidney damage, which can lead to kidney failure.² Many patients are unaware they have the condition until significant kidney ...
Landmark study reveals survival limits of kidney transplantation in older and high-risk patients
2025-06-04
(Vienna, Austria, Thursday 5 June 2025) A major international study, being presented today at the 62nd ERA Congress, reveals that the long-accepted survival advantage of deceased-donor kidney transplantation does not extend equally to every patient and every donor organ.1,2
A large-scale analysis, drawing on data from the European Renal Association (ERA) Registry, examined five-year survival outcomes in 64,013 wait-listed adults across Catalonia, Denmark, France, Norway, and the UK who began dialysis between 2000 and 2019. Using a robust target trial emulation (TTE) framework designed to mirror ...
Targeting mitochondria to fight leukemia: Rice University-led research team pursues new treatment strategies
2025-06-04
Acute myeloid leukemia (AML) remains one of the most aggressive and deadly forms of blood cancer, even as treatments have advanced in recent years. Standard approaches like high-dose chemotherapy and bone marrow transplants can extend life but often come at the cost of severe side effects — and many patients still relapse due to drug-resistant cancer cells.
A research team led by Natasha Kirienko at Rice University is working to change that by turning the cancer cells’ own energy ...
Antibiotics taken during pregnancy may reduce preterm births
2025-06-04
A study of almost 1000 pregnant women in Zimbabwe found that a daily dose of a commonly used, safe and inexpensive antibiotic may have led to fewer babies being born early. Among women living with HIV, those who received the antibiotic had larger babies who were less likely to be preterm.
One in four live-born infants worldwide is preterm (born at 37 weeks’ gestation or before), is small for gestational age, or has a low birth weight. The mortality rate for these small and vulnerable newborns is high, with prematurity now the leading cause of death among ...
Vigilance and targeted public health measures are essential in the face of the diphtheria epidemic that has affected vulnerable populations in Western Europe since 2022
2025-06-04
A study published in the New England Journal of Medicine (NEJM) reveals that the largest diphtheria epidemic in Western Europe for 70 years, which broke out in 2022 among migrants and in 2023 spread to other vulnerable populations in several European countries, is the result of contaminations occurring during migratory travel or in destination European countries, and not in the countries of origin. However, the geographical area and conditions of these initial contaminations are still unknown. A genetic link has also been established between the strain that circulated during the 2022 epidemic and an epidemic that occurred in Germany in 2025, suggesting ...
New study: Personalized exercise boosts health for people with neuromuscular disease
2025-06-04
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, JUNE 4, 2025
MINNEAPOLIS — While many people with neuromuscular diseases currently face a future without a cure, a new study finds that a personalized exercise and coaching program could improve their fitness and overall health. The study is published on June 4, 2025, online in Neurology®, the medical journal of the American Academy of Neurology.
The study looked at people with a variety of neuromuscular diseases that cause muscle weakness and loss, including ...